Bavituximab Active Not Recruiting Phase 2 Trials for Glioblastomas Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03139916Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma